PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Chaturvedi, Nishi
TI  - Candesartan Slows the Onset of Retinopathy in Patients with Type 1 Diabetes
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 14--15
VI  - 8
IP  - 7
4099  - http://mdc.sagepub.com/content/8/7/14.short
4100  - http://mdc.sagepub.com/content/8/7/14.full
AB  - Treatment with an angiotensin-II receptor blocker may slow the development of retinopathy among patients with type 1 diabetes, according to findings from the Diabetic Retinopathy Candesartan Trials [DIRECT] Study Programme. Although the primary endpoint was not met, secondary findings suggest that inhibition of the renin-angiotensin system may lessen the risk of microvascular complications in this patient population.